Crinetics is seeking to change the way acromegaly is treated. Ahead of its hopes for a 2025 U.S. drug launch, the biotech is looking to spread awareness about how to treat the condition.

Acromegaly Awareness Day is an annual global campaign on Nov. 1 to raise awareness and reduce the time it takes for people with acromegaly to get a diagnosis. ARTICLE CONTINUES BELOW Currently, ...

Company continues to advance its novel octreotide capsules candidate through Phase 3 clinical trials in the U.S. and E.U.WALTHAM, Mass., Nov. 01, ...

NEEDHAM, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA) today recognizes Acromegaly Awareness Day, which is observed every year on November 1, and reiterates its commitment ...

The Fort Lauderdale man, better known as “Froggy,” the morning radio host for “Y-100” WHYI (100.7-FM), had been suffering from symptoms of a rare disease, acromegaly.

Today is Acromegaly Awareness Day, an opportunity to teach Canadians about this rare disease. VANCOUVER, Nov. 1, 2018 /CNW Telbec/ - Acromegaly is a rare disease in adults which is difficult to ...

NEEDHAM, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA) today recognizes Acromegaly Awareness Day, which is observed every year on November 1, and reiterates its commitment ...